Document is current
Any future updates will be listed below
-
Authors
Mazloomian, Alborz
Araki, Shinsuke https://orcid.org/0000-0002-9936-1417
Ohori, Momoko https://orcid.org/0000-0002-4504-6032
El-Naggar, Amal M. https://orcid.org/0000-0002-3202-6171
Yap, Damian https://orcid.org/0000-0002-5370-4592
Bashashati, Ali
Nakao, Shoichi
Sorensen, Poul H.
Nakanishi, Atsushi
Shah, Sohrab https://orcid.org/0000-0001-6402-523X
Aparicio, Samuel https://orcid.org/0000-0002-0487-9599
-
Funding
Funding for this research was provided by:
Canada Excellence Research Chairs, Government of Canada (950-230610)
Gouvernement du Canada | Canadian Institutes of Health Research (FDN-148429)
Canadian Cancer Society Research Institute (705617)
Terry Fox Research Institute (1082)
BC Cancer Foundation, Canadian Foundation for Innovation / BC Knowledge Development Fund 37271.
- License Information
-
More Information
Article History
Received: 19 December 2018
Accepted: 11 March 2019
First Online: 3 May 2019
Competing interests
: The respective authors listed declare Competing Financial Interests: S. Araki, M.O., S.N. and A.N. are employees of Takeda Pharmaceutical Company. Takeda Pharmaceutical Company also provided partial funding support for the project and A.M. and gave access to chemical probes for this study. S. S. and S. Aparicio are founders and shareholders of Contextual Genomics Inc. S. Aparicio is a scientific advisor to Repare Therapeutics and Sangamo Pharmaceuticals. The remaining authors declare no competing interests.
